Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2024-10-04 00:00:00 ET · period of report 2024-10-02 · accession 0001104659-24-106328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-04 | 2024-10-02 | OCUL | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +100.0K | 216.0K | +86% | $0 |
| D | 2024-10-04 | 2024-10-02 | OCUL | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-02 | A | A | 100,000 | $0.00 | 215,984 | D | — | — | (F1) On October 2, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on October 1, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-10-02 | A | A | 200,000 | $0.00 | 200,000 | D | $9.31 · — to 2034-10-01 | 200,000 Common Stock | (F2) Vests over four years, with 1/48 of the shares vesting monthly beginning on November 1, 2024. |